ESC Premium Access

Valve repair and assist devices

Event: ESC CONGRESS 2016
Topic: Mitral valve surgery
Session type: Moderated Posters
Date: 30 August 2016
Time: 15:35 - 16:25

Congress Session

7 presentations in this session

Long-term outcome of mitral valve repair versus replacement in a large series of patients with infective endocarditis

Speaker: Associate Professor E. Ruttmann-Ulmer (Innsbruck, AT)

Comparison of contemporary risk scores for predicting mortality and morbidity after mitral valve surgery

Speaker: Doctor T. Wang (Cleveland, US)

Performance of existing clinical prediction models for predicting mortality after transcatheter aortic valve implantation

Speaker: Mr G. Martin (Manchester, GB)

Metabolic syndrome affects valve-related adverse events after biological heart valve replacement

Speaker: Doctor E. Angeloni (Rome, IT)

Can TAVI patients receive aspirin monotherapy as patients after surgical aortic bioprosthesis implantation? Data from the Polish Registry POL-TAVI.

Speaker: Doctor K. Czerwinska-Jelonkiewicz (London, GB)

Preservation of arterial pulsatility to prevent acquired von willebrand disease with continuous-flow left ventricular assist device : insights from a pig model

Speaker: Doctor F. Vincent (Lille, FR)

A novel autologous heart valve with growth potential

Speaker: Doctor Y. Takewa (Asahikawa, JP)

7 speakers from this session

Associate Professor Elfriede Ruttmann-Ulmer

Innsbruck Medical University, Innsbruck (Austria)
0 follower

Doctor Tom Kai Ming Wang

Cleveland Clinic, Cleveland (United States of America)
0 follower

Mr Glen Martin

University of Manchester, Manchester (United Kingdom of Great Britain & Northern Ireland)
0 follower

Doctor Emiliano Angeloni

BIOS Prevention, Rome (Italy)
0 follower

Doctor Katarzyna Czerwinska-Jelonkiewicz

Harefield Hospital, Royal Brompton and Harefield NHS Foundation Trust, London (United Kingdom of Great Britain & Northern Ireland)
5 presentations
1 follower

Doctor Flavien Vincent

Lille University Hospital, Lille (France)
0 follower

Doctor Yoshiaki Takewa

Asahikawa Medical University, Asahikawa (Japan)
0 follower

This platform is supported by

logo Novo Nordisk